Canadian Press NewsAlert:Valeant confirms US$8.7-billion deal for Bausch + Lomb

LAVAL, Que. – Valeant Pharmacueticals Inc. is buying Bausch + Lomb Holdings for US$8.7 billion in cash. The Montreal-area company will finance the deal by issuing up to $2 million of new equity, with the remainder paid for with debt.

More coming

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.